Stocklytics Platform
Asset logo for symbol NPCE
NeuroPace
NPCE70
$11.97arrow_drop_up0.50%$0.06
High Growth
Asset logo for symbol NPCE
NPCE70

$11.97

arrow_drop_up0.50%

Trendlines, Support and Resistance

lock

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Technical Indicators

NameValueActioninfoPnL (10y)Last upd.
RSI68.90Neutral19.7%
MACD33.21Neutral955.9%
CCI181.61Sell261.4%
ADX31.96Neutral-
ATR65.18Buy-
WILLR-21.43Neutral331.4%
ROC132.99Neutral609.7%
STOCHRSI92.29Sell103.7%

Indicator Ratings

Hold

Buy
1
-87.50%
Hold
5
-37.50%
Sell
2
-75.00%
Ratings from: January
Total: 8
info

Balanced or Uncertain

This suggests that the technical indicators do not strongly favor either a buying or selling stance. In such cases, investors may need to rely on additional fundamental or market analysis to make a well-informed decision.

NeuroPace (NPCE) Technical Analysis

NeuroPace, Inc. (NPCE) is a medical technology company that specializes in developing and commercializing implantable devices for the treatment of neurological disorders. The company's flagship product, the RNS System, is a responsive neurostimulation device that is designed to detect and respond to abnormal brain activity in patients with epilepsy. By delivering targeted electrical stimulation to the brain, the RNS System aims to reduce the frequency and severity of seizures in individuals who have not responded to traditional medication therapies.
Technical analysis of NeuroPace, Inc. (NPCE) stock can provide insights into the potential future price movements of the stock. One commonly used technical indicator is the Relative Strength Index (RSI), which measures the momentum of a stock by comparing the magnitude of recent gains and losses. A high RSI value suggests that the stock is overbought and may be due for a price correction, while a low RSI value indicates that the stock may be oversold and could potentially rebound. Another useful indicator is the Average Directional Index (ADX), which measures the strength of a stock's trend. A high ADX value suggests that the stock is trending strongly, while a low ADX value indicates a weak or indecisive trend. The Moving Average Convergence Divergence (MACD) is a trend-following momentum indicator that calculates the difference between two exponential moving averages. A positive MACD value suggests bullish momentum, while a negative value indicates bearish momentum. The Rate of Change (ROC) is another useful indicator that measures the percentage change in a stock's price over a specified time period. The Stock RSI (STOCHRSI) is a momentum oscillator that measures the level of overbought or oversold conditions in a stock. A high STOCHRSI value indicates overbought conditions, while a low value suggests oversold conditions. Finally, the Williams %R (WILLR) is a momentum indicator that measures overbought or oversold conditions. A WILLR value above -20 suggests overbought conditions, while a value below -80 indicates oversold conditions. Based on the technical analysis indicators for NeuroPace, Inc. (NPCE) stock, it is important for investors to closely monitor the RSI, ADX, MACD, ROC, STOCHRSI, and WILLR to assess the stock's potential future price movements.
add NeuroPace to watchlist

Keep an eye on NeuroPace

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What are the technical signals for NeuroPace (NPCE) stock based on the last 30 days?

The technical analysis for NeuroPace (NPCE), using 8 key indicators (RSI, MACD, CCI, ADX, ATR, WILLR, ROC, STOCHRSI) over the last 30 days, reveals: 1 technical buy signals, including ATR. 1 technical sell signals, identified by STOCHRSI. 6 technical hold signals, associated with RSI, MACD, CCI, ADX, WILLR, and ROC. This analysis was last updated 2025 Jan 20.

Take Your Investments to a Whole New Level